KESTON TRAMMELL: Open Payments
NPI 1427430974 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 33 payments from 13 companies in 2025. Trend: 2023 $691 · 2024 $1,306 · 2025 $896
Food & beverage: $859Education: $37
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $141 |
| Merck Sharp & Dohme LLC | 8 | $137 |
| Medtronic, Inc. | 2 | $119 |
| Lilly USA, LLC | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Novo Nordisk Inc | 1 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| SCPHARMACEUTICALS INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| PFIZER INC. | 2 | $40 |
Products named: REPATHA, VERQUVO, SYMPLICITY G3, JARDIANCE, Ozempic, FUROSCIX, FARXIGA, LEQVIO.
Industry payments across AL — which companies pay providers there.
